Director, BRAF Melanoma Marketing & Pan-Tumor

ROLE SUMMARY:

• BRAFTOVI (encorafenib) & MEKTOVI (binimetinib) are key to therapies within the Pfizer Oncology Precision Medicine franchise, with a strong future of growth through the end of the decade

• The portfolio covers three indications: 

• Metastatic Melanoma: BRAFTOVI + MEKTOVI received approval in BRAF mutant metastatic melanoma in 2018 

• Colon Cancer: BRAFTOVI + cetuximab received approval as the first and only targeted therapy in 2L+ BRAF mutant metastatic colorectal cancer in April 2020; an earlier line indication is expected in the 2024-25 timeframe 

• Lung Cancer: BRAFTOVI + MEKTOVI received approval for BRAF mutant metastatic lung cancer in 2023 

• There is significant growth expected from this portfolio over the next 3-4 years and will be an important priority brand within Pfizer Oncology 

• The Director, BRAF Melanoma Marketing & Pan-Tumor will report to the US Mel/CRC Marketing Team Lead 

• This position requires strong strategic, analytical and execution skills, interpersonal and communication skills, and agility to learn and work across multiple stakeholders

ROLE RESPONSIBILITIES:

• The Director, BRAF Melanoma Marketing & Pan-Tumor will partner with the Melanoma Indication Lead and Mel/CRC Marketing TL to deliver on key BRAFTOVI & MEKTOVI Melanoma strategies, as well as drive multiple pan-tumor marketing efforts across the three indications of BRAFTOVI & MEKTOVI.

Melanoma focused responsibilities include:  

• Lead development and execution of Melanoma promotional efforts across both all key stakeholders (ie HCPs, and Consumer marketing patients, health systems) 

• Collaborate and provide insight with Melanoma Strategy Lead in development of Melanoma Strategy for BRAFTOVI & MEKTOVI 

• Engage with field team members and KOLs as appropriate to stay up-to-date on Melanoma competitive landscape and key business drivers 

• Collaborate with ISE (Insights Strategy & Execution) Team to derive insights from market research and performance and analytics reports across the Melanoma business. 

Pan-Tumor focused responsibilities include: 

• Collaborate with indication leads on the development of Media Strategy (HCP and Consumer) and lead execution of media tactics with agency(s) 

• Lead peer-to-peer strategy and third party programs, including management of speaker prog ram content and speaker bureaus 

• Liaise with Account and Payer Marketing teams to ensure that brand strategies are carried through for execution executed by those marketing teams.  

BASIC QUALIFICATIONS:

• BA/BS required and 10+ years of pharmaceutical marketing experience 

• Experience in working with different channels i.e. digital

• Has